Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1
批准号:
8079758
负责人:
Manish Sagar
金额:
$34.26万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2012-06-30
关键词:
AddressAffinityAfricaAntibodiesBinding SitesBiologicalBiological ModelsCCR5 geneCell CommunicationCell LineCellsCharacteristicsChemokine (C-C Motif) Receptor 5ChronicChronic PhaseCoculture TechniquesCouplesDataDendritic CellsDependenceEvaluationGenotypeGlycoproteinsGoalsHIVHIV InfectionsHIV-1HealthHeterosexualsImmune responseInfectionKineticsLangerhans cellLengthModificationMolecularMolecular ConformationParentsPathogenesisPhenotypePhylogenetic AnalysisPropertyReceptor CellSamplingStructureT-LymphocyteTestingTimeUgandaVariantVertebral columnViralViremiaViruscell typecohortfitnessglycoprotein structureinhibitor/antagonistinsightmacrophagemicrobicidemonocytenovelpreventreceptorreceptor bindingrecombinant virustransmission process
中文摘要
描述(由申请人提供):本提案的长期目标是更好地了解HIV-1在异性传播中的发病机制。先前的研究在感染后早期检查受试者,但主要是在HIV-1血清转化后,已经产生了有价值的见解。例如,我们和其他人已经表明,新感染的受试者只从传播伴侣中传播的病毒变体阵列中获得病毒的子集。此外,具有紧凑和较少糖基化变体的病毒更容易在异性间传播。在异性传播过程中,这些包膜基因型选择的生物学机制尚不清楚。病毒包膜糖蛋白结构预示着较短且糖基化程度较低的包膜具有更开放的构象,从而增强了对宿主细胞受体的亲和力,并且可能具有更高的抗体中和敏感性。由于在宿主体液免疫反应的情况下,包膜修饰可以在感染后不久发生,因此我们建议评估和比较HIV-1血清转化前新感染受体及其传播伴侣的包膜特性。我们将研究受体相互作用和来自受体和供体的包膜的细胞感染效率。此外,我们将测试是否通过更好的病毒包膜糖蛋白-宿主细胞受体相互作用来提高感染宿主细胞的效率,从而使其适合传播。我们的研究旨在研究在异性传播过程中为病毒提供优势的潜在生物学机制。我们的研究可能对使用受体和融合抑制剂来阻止病毒进入的杀微生物剂有重要意义。公共卫生相关性:我们建议的目的是确定在传播过程中影响特定HIV-1变异选择的生物学机制。我们建议研究一组新的不一致配对,以独特地解决新传播病毒和传播伙伴中大多数变异之间的受体亲和力和融合动力学差异。我们将探索观察到的这些表型特性差异的生物学相关性,以开发HIV-1传播过程中选择的潜在生物学模型。
英文摘要
DESCRIPTION (provided by applicant): The long term objectives of this proposal are to provide a better understanding of the pathogenesis of HIV-1 during heterosexual transmission. Previous studies examining subjects early after infection, but primarily after HIV-1 seroconversion, have yielded valuable insights. For instance, we and other have shown that newly infected subjects only acquire a subset of viruses from the array of viral variants circulating in the transmitting partner. In addition, viruses with compact and less glycosylated variants are favored for heterosexual transmission. The biological mechanism for the selection of these envelope genotypes during heterosexual transmission remains undefined. The viral envelope glycoprotein structure would predict that short and less glycosylated envelopes would have more open conformations leading to an enhanced affinity for host cell receptors and possibly greater antibody neutralization sensitivity. Because envelope modifications can occur soon after infection in the setting of the host humoral immune response, we propose to evaluate and compare envelope properties from newly infected recipients sampled prior to HIV-1 seroconversion and their transmitting partner. We will investigate receptor interactions and cell infection efficiencies of the envelopes from recipients and donors. In addition, we will test whether greater efficiency in infecting host cells through better viral envelope glycoprotein-host cell receptor interactions could confer fitness for transmission. Our studies aim to examine potential biological mechanisms that provide an advantage for viruses during heterosexual transmission. Our studies could have significant implications for microbicides efforts aimed at using receptor and fusion inhibitors to prevent viral entry. PUBLIC HEALTH RELEVANCE: The aim of our proposal is to define the biological mechanisms that influence the selection of specific HIV-1 variants during transmission. We propose to examine a novel cohort of discordant couples to uniquely address receptor affinity and fusion kinetics differences among newly transmitted viruses and the majority of variants in the transmitting partner. We will explore the biological relevance of observed differences in these phenotypic properties to develop potential biological models for selection during HIV-1 transmission.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Clinical implications of new findings in HIV basic research.
HIV基础研究新发现的临床意义。
DOI:
10.2217/hiv.09.20
发表时间:
2009
期刊:
HIV therapy
影响因子:
--
作者:
[Sagar,Manish]
通讯作者:
Sagar,Manish
DOI:
10.1186/1742-4690-10-162
发表时间:
2013-12-26
期刊:
Retrovirology
影响因子:
3.3
作者:
[Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, Reynolds SJ, Laeyendecker O, Gray RH, Serwadda D, Lee SJ, Quinn TC, Sagar M]
通讯作者:
Sagar M
Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics.
单基因组扩增和标准散装PCR产生具有相似基因型和表型特征的HIV-1包膜产物。
DOI:
10.1016/j.jviromet.2015.01.006
发表时间:
2015-03
期刊:
Journal of virological methods
影响因子:
3.1
作者:
[Etemad B, Ghulam-Smith M, Gonzalez O, White LF, Sagar M]
通讯作者:
Sagar M
Sartorious Octet R8 System
-
批准号:10429632
-
项目类别:
-
资助金额:$24.91万
-
财政年份:2022
-
负责人:Manish Sagar
-
依托单位:
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
-
批准号:10707299
-
项目类别:
-
资助金额:$70.39万
-
财政年份:2022
-
负责人:Manish Sagar
-
依托单位:
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
-
批准号:10630722
-
项目类别:
-
资助金额:$69.98万
-
财政年份:2022
-
负责人:Manish Sagar
-
依托单位:
HIV-1 mucosal transmission and persistence
-
批准号:10355517
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2019
-
负责人:Manish Sagar
-
依托单位:
HIV-1 mucosal transmission and persistence
-
批准号:10116270
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2019
-
负责人:Manish Sagar
-
依托单位:
HIV-1 mucosal transmission and persistence
-
批准号:10596478
-
项目类别:
-
资助金额:$18.17万
-
财政年份:2019
-
负责人:Manish Sagar
-
依托单位:
Identification and characterization of individuals with elite anti-HIV-1 ADCC
-
批准号:9757695
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2018
-
负责人:Manish Sagar
-
依托单位:
The effects of opioid use on HIV-1 reservoir dynamics
-
批准号:10673865
-
项目类别:
-
资助金额:$88.36万
-
财政年份:2018
-
负责人:Manish Sagar
-
依托单位:
The effects of opioid use on HIV-1 reservoir dynamics
-
批准号:10620076
-
项目类别:
-
资助金额:$89.75万
-
财政年份:2018
-
负责人:Manish Sagar
-
依托单位:
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract
-
批准号:8846903
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2015
-
负责人:Manish Sagar
-
依托单位:
CD1a Vaginal Dendritic Cells and HIV-1 Acquisition in the Female Genital Tract
-
批准号:9145066
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2015
-
负责人:Manish Sagar
-
依托单位:
Neutralizing and non-neutralizing antibodies protection from breast milk HIV-1
-
批准号:8520179
-
项目类别:
-
资助金额:$19.86万
-
财政年份:2012
-
负责人:Manish Sagar
-
依托单位:
Neutralizing and non-neutralizing antibodies protection from breast milk HIV-1
-
批准号:8410694
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2012
-
负责人:Manish Sagar
-
依托单位:
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1
-
批准号:7645869
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2008
-
负责人:Manish Sagar
-
依托单位:
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1
-
批准号:7554819
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2008
-
负责人:Manish Sagar
-
依托单位:
Genotypic and Phenotypic Characterization of Heterosexually Transmitted HIV-1
-
批准号:7890493
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2008
-
负责人:Manish Sagar
-
依托单位:
The role of viral diversity in HIV-1 drug resistance
-
批准号:7065203
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2002
-
负责人:Manish Sagar
-
依托单位:
The role of viral diversity in HIV-1 drug resistance
-
批准号:6725453
-
项目类别:
-
资助金额:$12.29万
-
财政年份:2002
-
负责人:Manish Sagar
-
依托单位:
The role of viral diversity in HIV-1 drug resistance
-
批准号:6553795
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2002
-
负责人:Manish Sagar
-
依托单位:
The role of viral diversity in HIV-1 drug resistance
-
批准号:6640629
-
项目类别:
-
资助金额:$11.21万
-
财政年份:2002
-
负责人:Manish Sagar
-
依托单位:
海外基金